Jennifer L Kemppainen
Overview
Explore the profile of Jennifer L Kemppainen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bandel L, Vierkant R, Kruisselbrink T, Bublitz M, Wilson T, Armasu S, et al.
Mayo Clin Proc
. 2024 Dec;
PMID: 39625429
Objective: To execute a large-scale, decentralized, clinical-grade whole exome sequencing study, coined Tapestry, for clinical practice, research discovery, and genomic education. Patients And Methods: Between July 1, 2020, and May...
2.
Samadder N, Gay E, Lindpere V, Bublitz M, Bandel L, Armasu S, et al.
JCO Precis Oncol
. 2024 Jul;
8:e2400106.
PMID: 39013133
Purpose: The autosomal dominant cancer predisposition disorders hereditary breast and ovarian cancer (HBOC) and Lynch syndrome (LS) are genetic conditions for which early identification and intervention have a positive effect...
3.
Wilke M, Klee E, Dhamija R, Fervenza F, Thomas B, Leung N, et al.
Orphanet J Rare Dis
. 2024 May;
19(1):216.
PMID: 38790019
Background: Though next-generation sequencing (NGS) tests like exome sequencing (ES), genome sequencing (GS), and panels derived from exome and genome data (EGBP) are effective for rare diseases, the ideal diagnostic...
4.
Pinto E Vairo F, Kemppainen J, Vitek C, Whalen D, Kolbert K, Sikkink K, et al.
J Transl Med
. 2024 Apr;
22(1):400.
PMID: 38689323
No abstract available.
5.
Pinto E Vairo F, Kemppainen J, Vitek C, Whalen D, Kolbert K, Sikkink K, et al.
J Transl Med
. 2023 Jun;
21(1):410.
PMID: 37353797
Background: In the United States, rare disease (RD) is defined as a condition that affects fewer than 200,000 individuals. Collectively, RD affects an estimated 30 million Americans. A significant portion...
6.
Chen X, Meyer M, Kemppainen J, Horibe M, Chandra S, Majumder S, et al.
JAMA Oncol
. 2023 May;
9(7):955-961.
PMID: 37200008
Importance: Increased cancer risk in first-degree relatives of probands with pancreatic ductal adenocarcinoma (PDAC probands) who carry pathogenic or likely pathogenic germline variants (PGVs) in cancer syndrome-associated genes encourages cascade...
7.
Klee E, Cousin M, Pinto E Vairo F, Morales-Rosado J, Macke E, Jenkinson W, et al.
Genet Med
. 2023 Feb;
25(2):100359.
PMID: 36745126
No abstract available.
8.
Rabe K, Stevens M, Hernandez A, Chandra S, Hubbard J, Kemppainen J, et al.
Genet Med
. 2022 Mar;
24(5):1008-1016.
PMID: 35227607
Purpose: Pancreatic cancer (PC) risk is increased in families, but PC risk and risk perception have been understudied when both parents have cancer. Methods: An unbiased method defining cancer triads...
9.
Schalk A, Cousin M, Dsouza N, Challman T, Wain K, Powis Z, et al.
J Med Genet
. 2021 Dec;
59(10):965-975.
PMID: 34930816
Background: High-impact pathogenic variants in more than a thousand genes are involved in Mendelian forms of neurodevelopmental disorders (NDD). Methods: This study describes the molecular and clinical characterisation of 28...
10.
Pinto E Vairo F, Prochnow C, Kemppainen J, Lisi E, Steyermark J, Kruisselbrink T, et al.
Kidney Med
. 2021 Nov;
3(5):785-798.
PMID: 34746741
Rationale & Objective: The etiology of kidney disease remains unknown in many individuals with chronic kidney disease (CKD). We created the Mayo Clinic Nephrology Genomics Clinic to improve our ability...